Advertisement
LMAT vs RDNT
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is LMAT is a Buy and RDNT is a Hold.
LMAT in upward trend: 10-day moving average broke above 50-day moving average on October 15, 2026
The 10-day moving average for LMAT crossed bullishly above the 50-day moving average on October 15, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 15 of 17 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 88%.
Technical Analysis (Indicators)
Bullish Trend Analysis
The Momentum Indicator moved above the 0 level on October 14, 2026. You may want to consider a long position or call options on LMAT as a result. In 76 of 104 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 73%.
LMAT moved above its 50-day moving average on October 19, 2026 date and that indicates a change from a downward trend to an upward trend.
Following a +2.31% 3-day Advance, the price is estimated to grow further. Considering data from situations where LMAT advanced for three days, in 229 of 339 cases, the price rose further within the following month. The odds of a continued upward trend are 68%.
The Aroon Indicator entered an Uptrend today. In 167 of 235 cases where LMAT Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 71%.
Bearish Trend Analysis
The Stochastic Oscillator has been in the overbought zone for 1 day. Expect a price pull-back in the near future.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where LMAT declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 54%.
LMAT broke above its upper Bollinger Band on September 28, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
Fundamental Analysis (Ratings)
The Tickeron SMR rating for this company is 52 (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 52 (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock slightly better than average.
The Tickeron Price Growth Rating for this company is 60 (best 1 - 100 worst), indicating fairly steady price growth. LMAT’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Valuation Rating of 74 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (4.642) is normal, around the industry mean (4.961). P/E Ratio (29.628) is within average values for comparable stocks, (37.232). Projected Growth (PEG Ratio) (2.178) is also within normal values, averaging (4.143). Dividend Yield (0.012) settles around the average of (0.005) among similar stocks. P/S Ratio (7.267) is also within normal values, averaging (56.876).
The Tickeron PE Growth Rating for this company is 79 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
Momentum Indicator for RDNT turns positive, indicating new upward trend
RDNT saw its Momentum Indicator move above the 0 level on October 22, 2026. This is an indication that the stock could be shifting in to a new upward move. Traders may want to consider buying the stock or buying call options. Tickeron's A.I.dvisor looked at 86 similar instances where the indicator turned positive. In 70 of the 86 cases, the stock moved higher in the following days. The odds of a move higher are at 81%.
Technical Analysis (Indicators)
Bullish Trend Analysis
The Moving Average Convergence Divergence (MACD) for RDNT just turned positive on October 22, 2026. Looking at past instances where RDNT's MACD turned positive, the stock continued to rise in 42 of 55 cases over the following month. The odds of a continued upward trend are 76%.
Following a +1.23% 3-day Advance, the price is estimated to grow further. Considering data from situations where RDNT advanced for three days, in 233 of 315 cases, the price rose further within the following month. The odds of a continued upward trend are 74%.
Bearish Trend Analysis
The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In 44 of 59 cases where RDNT's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are 75%.
RDNT moved below its 50-day moving average on September 29, 2026 date and that indicates a change from an upward trend to a downward trend.
The 10-day moving average for RDNT crossed bearishly below the 50-day moving average on October 01, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 8 of 10 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 80%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where RDNT declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 74%.
The Aroon Indicator for RDNT entered a downward trend on October 19, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Fundamental Analysis (Ratings)
The Tickeron Valuation Rating of 1 (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (5.045) is normal, around the industry mean (66.046). RDNT's P/E Ratio (-270.231) is considerably lower than the industry average of (2.422). Projected Growth (PEG Ratio) (0.260) is also within normal values, averaging (3.473). Dividend Yield (0.000) settles around the average of (0.002) among similar stocks. P/S Ratio (2.567) is also within normal values, averaging (9.775).
The Tickeron Profit vs. Risk Rating rating for this company is 45 (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 89, placing this stock slightly better than average.
The Tickeron Price Growth Rating for this company is 49 (best 1 - 100 worst), indicating fairly steady price growth. RDNT’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron PE Growth Rating for this company is 60 (best 1 - 100 worst), pointing to average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron SMR rating for this company is 91 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
LMAT | RDNT | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 43 | 4 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 74 Overvalued | 1 Undervalued | |
PROFIT vs RISK RATING 1..100 | 52 | 45 | |
SMR RATING 1..100 | 52 | 91 | |
PRICE GROWTH RATING 1..100 | 60 | 49 | |
P/E GROWTH RATING 1..100 | 79 | 60 | |
SEASONALITY SCORE 1..100 | 50 | n/a |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
RDNT's Valuation (1) in the Medical Or Nursing Services industry is significantly better than the same rating for LMAT (74) in the Medical Specialties industry. This means that RDNT’s stock grew significantly faster than LMAT’s over the last 12 months.
RDNT's Profit vs Risk Rating (45) in the Medical Or Nursing Services industry is in the same range as LMAT (52) in the Medical Specialties industry. This means that RDNT’s stock grew similarly to LMAT’s over the last 12 months.
LMAT's SMR Rating (52) in the Medical Specialties industry is somewhat better than the same rating for RDNT (91) in the Medical Or Nursing Services industry. This means that LMAT’s stock grew somewhat faster than RDNT’s over the last 12 months.
RDNT's Price Growth Rating (49) in the Medical Or Nursing Services industry is in the same range as LMAT (60) in the Medical Specialties industry. This means that RDNT’s stock grew similarly to LMAT’s over the last 12 months.
RDNT's P/E Growth Rating (60) in the Medical Or Nursing Services industry is in the same range as LMAT (79) in the Medical Specialties industry. This means that RDNT’s stock grew similarly to LMAT’s over the last 12 months.
| LMAT | RDNT | |
|---|---|---|
| RSI ODDS (%) | N/A | N/A |
| Stochastic ODDS (%) | 1 day ago 64% | 1 day ago 75% |
| Momentum ODDS (%) | 1 day ago 73% | 1 day ago 81% |
| MACD ODDS (%) | N/A | 1 day ago 76% |
| TrendWeek ODDS (%) | 1 day ago 70% | 1 day ago 73% |
| TrendMonth ODDS (%) | 1 day ago 68% | 1 day ago 75% |
| Advances ODDS (%) | 1 day ago 68% | 3 days ago 74% |
| Declines ODDS (%) | 21 days ago 54% | 15 days ago 74% |
| BollingerBands ODDS (%) | 1 day ago 65% | N/A |
| Aroon ODDS (%) | 1 day ago 71% | 1 day ago 84% |
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
LMAT’s FA Score shows that 0 FA rating(s) are green while RDNT’s FA Score has 1 green FA rating(s).
- LMAT’s FA Score: 0 green, 5 red.
- RDNT’s FA Score: 1 green, 4 red.
Short-Term Analysis
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
LMAT’s TA Score shows that 5 TA indicator(s) are bullish while RDNT’s TA Score has 1 bullish TA indicator(s).
- LMAT’s TA Score: 5 bullish, 3 bearish.
- RDNT’s TA Score: 1 bullish, 7 bearish.
Price Growth
LMAT (@Pharmaceuticals: Other) experienced а +2.61% price change this week, while RDNT (@Medical Specialties) price change was -1.08% for the same time period.
The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was +0.59%. For the same industry, the average monthly price growth was -3.91%, and the average quarterly price growth was +7.47%.
The average weekly price growth across all stocks in the @Medical Specialties industry was -3.15%. For the same industry, the average monthly price growth was -6.50%, and the average quarterly price growth was +42.74%.
Reported Earning Dates
LMAT is expected to report earnings on Nov 04, 2026.
RDNT is expected to report earnings on Nov 09, 2026.
Industries' Descriptions
@Pharmaceuticals: Other (+0.59% weekly)Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.
@Medical Specialties (-3.15% weekly)Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.
Advertisement
LMAT and
Correlation & Price change
A.I.dvisor indicates that over the last year, LMAT has been loosely correlated with ITGR. These tickers have moved in lockstep 48% of the time. This A.I.-generated data suggests there is some statistical probability that if LMAT jumps, then ITGR could also see price increases.
| Ticker / NAME | Correlation To LMAT | 1D Price Change % | ||
|---|---|---|---|---|
| LMAT | 100% | +1.98% | ||
| ITGR - LMAT | 48% Loosely correlated | -0.11% | ||
| SYK - LMAT | 46% Loosely correlated | +3.19% | ||
| UFPT - LMAT | 44% Loosely correlated | +2.49% | ||
| AORT - LMAT | 40% Loosely correlated | +4.67% | ||
| RDNT - LMAT | 39% Loosely correlated | +2.70% | ||
More | ||||
RDNT and
Correlation & Price change
A.I.dvisor indicates that over the last year, RDNT has been loosely correlated with ITGR. These tickers have moved in lockstep 49% of the time. This A.I.-generated data suggests there is some statistical probability that if RDNT jumps, then ITGR could also see price increases.
| Ticker / NAME | Correlation To RDNT | 1D Price Change % | ||
|---|---|---|---|---|
| RDNT | 100% | +2.70% | ||
| ITGR - RDNT | 49% Loosely correlated | -0.11% | ||
| GKOS - RDNT | 48% Loosely correlated | -0.09% | ||
| NNOX - RDNT | 46% Loosely correlated | -0.36% | ||
| ICUI - RDNT | 43% Loosely correlated | +4.66% | ||
| CERS - RDNT | 42% Loosely correlated | -3.35% | ||
More | ||||